NBGI Private Equity

NBGI Private Equity - Ventures

Sound judgement and commercial insight drawing on our own management experience in a wide variety of businesses.

04 October 2011

Cellnovo Receives 2011 European Technology Innovation Award in Diabetes Care

30 September 2011

Symetis’ ACURATE TA™ Aortic Bioprosthesis Receives CE Mark Certification on Sept. 30th 2011

Largest 2nd generation TAVI system clinical experience; Mid-term FIM study results to be presented at EACTS 2011 on October 3 in Lisbon.

19 September 2011

Cellnovo receives CE mark approval for world's first mobile diabetes management system

14 September 2011

Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting

13 September 2011

Cellnovo forms worldwide technology alliance with LifeScan

 

© 2011 NBGI Private Equity Limited. All rights reserved.
NBGI Private Equity Limited is Authorised and Regulated by the Financial Services Authority